Exciting updates & innovations in Clinical Genomics this July! - Launching novel multiplexed reference materials for NGS carrier screening assays - Webinar recap analysis of liquid biopsy assay validation challenges - Cutting-edge oncology research from AACR 2024 - Hereditary cancer testing poster from ESHG 2024 - Peer-reviewed publication on microsatellite instability detection Curious to learn more? Explore the full spectrum of our latest research and technological advancements here: https://hubs.ly/Q02J5lYk0 #ClinicalDiagnostics #CarrierScreening #LiquidBiopsy #CancerResearch
About us
LGC Clinical Diagnostics develops and manufactures a comprehensive portfolio of catalog and custom-developed diagnostic quality solutions, biological and reagent component materials for the extended life sciences industry. Our scientific expertise, together with our custom product development capabilities, further accelerates bringing your innovations to life. Together, we are changing the future of diagnostics. LGC Clinical Diagnostics has over 35 years of experience as a leading and trusted global manufacturer of Quality Management Tools (QMT) and reagent components. We partner with In Vitro Diagnostics (IVD) and biopharmaceutical developers, clinical research organizations (CROs) and academic institutions in commercialization activities across the entire diagnostic pipeline - from concept and early-stage research, through expedited product development and onwards into routine clinical use. Laboratories and diagnostic professionals across disciplines of clinical chemistry, immunochemistry, serology, molecular diagnostics, and clinical genomics rely on LGC’s products to achieve accurate and reliable diagnostic results. Our combined and ever-growing capabilities mean we are better positioned to support the needs of the clinical diagnostics industry, from early feasibility and research to commercial & laboratory development test (LDT) assay development, installation, validation and ongoing performance monitoring support. LGC Clinical Diagnostics Quality Management and reagent component manufacturing facilities are FDA-registered, and ISO 13485 and ISO 9001-certified. Our brands include Technopath Clinical Diagnostics, SeraCare, Biochemical Diagnostics, Inc., KOVA International, Maine Standards, and The Native Antigen Company. Together, our brands serve over 7,500 customers in over 120 countries, providing products for more than 20 clinical application areas, including infectious diseases, NIPT, diabetes, cardiac disease and oncology.
- Website
-
https://lgcclinicaldiagnostics.com
External link for LGC Clinical Diagnostics
- Industry
- Biotechnology
- Company size
- 1,001-5,000 employees
- Headquarters
- Milford, Massachusetts
- Type
- Privately Held
- Specialties
- linearity and calibration verification, reference materials, antigens and antibodies, research components, biological materials, Quality Measurement Tools, Informatics, and Quality Controls
Locations
Employees at LGC Clinical Diagnostics
Updates
-
VALIDATE® B-CTx is now available for Roche cobas®! Beta-CrossLaps are a fragment of type 1 collagen, they are produced during bone resorption. The markers are used to evaluate and monitor treatment response for patients with metabolic bone diseases (e.g. osteoporosis, Paget's disease, hyperthyroidism, hyperparathyroidism, Renal bone disease, or bone metastasis). Learn more: https://hubs.ly/Q02HJ06P0
-
-
CALENDAR NOTIFICATION! Stop by booth 2845 at ADLM 2024 in Chicago, IL July 28 - August 1 to speak to a member of the LGC Clinical Diagnostics and Biosearch Technologies Team. Also, be sure to add the Trichomonas Vaginalis and Mycoplasma Genitalium Control in Urine poster to your must-see list of Tuesday's 7/30 poster presentations in the poster hall from 1:30 - 2:30 PM CT. Learn more about access to the poster here: https://hubs.ly/Q02HrS4D0 OR schedule a meeting with one of our representatives by clicking on this link: https://hubs.ly/Q02HrQNp0 #ADLM2024 #scientificposter
ADLM 2024 - LGC Clinical Diagnostics
digital.lgcclinicaldiagnostics.com
-
Thank you for visiting us at Booth 103 during #ISPD2024 in Boston and making this event a great success. It's always wonderful connecting with all of you! If we missed you at the event or you’d like to connect now, feel free to reach out to discuss our offerings: https://hubs.ly/Q02Hjrbw0
Contact SeraCare Life Sciences | SeraCare
seracare.com
-
Exciting news! VALIDATE® CT is now available for Roche cobas®! Calcitonin is a hormone that helps regulate how the body uses calcium. It is produced by special cells in the thyroid called C-cells. The calcitonin test is primarily used to help diagnose C-cell hyperplasia and medullary thyroid cancer, to help determine whether treatment has been effective, and to monitor for recurrence of thyroid cancer. Learn more: https://hubs.ly/Q02G_s6C0
-
-
Introducing our Seraseq® Carrier Screening DNA Mix, a reference material for NGS carrier screening assays. Designed to develop, validate, and monitor expanded carrier screening tests, it ensures accurate detection of inherited genetic variants across 54 significant variants from 48 genes, covering disorders like #cysticfibrosis and #sicklecelldisease. How does it compare to existing solutions? Click to find out, and access our detailed product sheet and other free resources: https://hubs.ly/Q02GNPPW0 #GeneticTesting #NGS #CarrierScreening
Seraseq® Carrier Screening DNA Mix | SeraCare
seracare.com
-
LGC Clinical Diagnostics and Biosearch Technologies are attending ADLM 2024 in Chicago, IL July 28 - August 1 - come visit us at booth 2845! Learn more about our diagnostics and genomics one-stop-shop, OR schedule a meeting with one of our representatives by clicking on this link: https://hubs.ly/Q02GF6z80 #ADLM2024
Come visit us at booth 2845 at ADLM 2024!
digital.lgcclinicaldiagnostics.com
-
VALIDATE® CM2 has been optimized to meet market needs! Due to Roche Diagnostics discontinuing the Elecsys Troponin T and Elecsys Troponin T STAT assays, VALIDATE® CM2 (402re), for Roche cobas®, now offers High Sensitivity C-Reactive Protein (hs-CRP), N-Terminal Pro hormone Brain Natriuretic Peptide (NT-proBNP) and Troponin I (TnI) for easy, fast, efficient calibration verification and linearity testing. Troponin T has been removed as part of this enhancement. Learn more: https://hubs.ly/Q02GFyKn0
-
-
Ticks and tick-borne diseases (TBDs) are a growing global problem for human health. Currently, 18 tick-borne infectious pathogens, 20 conditions, and 13 illnesses are known to result from tick bites, and more continue to be identified. Check out our updated tick blog "Growing concern: tick-borne pathogens expand their reach" and uncover the need for accurate and reliable tick-borne diagnostic test methods. Read now: https://hubs.ly/Q02GbdST0 #tickbornepathogens #blogpost #moleculardiagnostics
Growing concern: tick-borne pathogens expand their reach
blog.lgcclinicaldiagnostics.com
-
Thank you for visiting us at Booth 5 last week at AMP Europe 2024 in Madrid. The event was a great success, and it was wonderful to connect with all of you. In review, here are some informative resources for you, such as posters from previous years' AMP event: https://hubs.ly/Q02G65pq0 #AMPEurope24 #ScientificPosters
-